BioLife Solutions announces special shareholder meeting on merger agreement
Reuters2026/09/09 21:22- BioLife Solutions will hold a special shareholder meeting via remote communication on Oct. 5, 2026.
- Shareholders will vote on adopting the merger agreement under which Repligen would acquire BioLife.
- Deal terms call for USD 11.25 in cash plus 0.1442 shares of Repligen common stock per BioLife share.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The 18-year S&P 100 inclusion will come to an end! Nike (NKE.US) urgently clarifies: It remains an S&P 500 constituent.
Nike is about to be removed from the S&P 100 Index, ending its nearly 18-year history as a component. In response to market questions regarding this development, Nike's investor relations team emphasized that this adjustment only pertains to the S&P 100 Index, and Nike remains a constituent of the S&P 500 Index.

Braskem unit Voqen extends Petrobras gas supply deal to 2029, valued at R$ 1.85 billion
Philip Morris Expands Zyn Nicotine Pouch Lineup, Adds More Pouches Per Can -- Update
CV Sciences discloses 10% stake held by beneficial owner Charles E. Cheever III in Form 3 filing